查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
伤口皮肤替代市场 - 全球和区域分析：区域/国家分析、竞争格局、分析和预测（2023-2030）
市场调查报告书
商品编码
1488258

伤口皮肤替代市场 - 全球和区域分析：区域/国家分析、竞争格局、分析和预测（2023-2030）

Wound Skin Substitutes Market - A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2030
出版日期: | 出版商: BIS Research | 英文 41 Pages | 商品交期: 1-5个工作天内

价格

全球伤口皮肤替代市场规模将从2022年的11.81亿美元增长到2030年的20.626亿美元，在2023年至2030年的预测期内以7.35%的复合年增长率稳步增长。

糖尿病足溃疡、压疮和腿部静脉溃疡等慢性伤口的增加急剧增加了对创新、有效的创伤治疗解决方案的需求。

主要市场统计数据
预测期 2023-2030
2023年评估 12.555 亿美元
2030年预测 20.626 亿美元
复合年增长率 7.35%

生物材料的技术进步和更有效的皮肤替代产品的开发进一步推动了这一增长。此外，更容易患慢性病的老年人口的增加以及世界医疗基础设施功能的不断扩大也对市场的扩张做出了重大贡献。进一步支持这一增长的是对改善患者治疗结果和降低与慢性伤口相关的整体医疗成本的日益关注。

北美地区在全球市场中占据主导地位，2022年份额将达到78.12%。这一巨大比例是由于多种因素造成的，包括人口老化、与糖尿病高度相关的肥胖症的迅速增加以及放射治疗的后期影响。这些因素进一步推动患者采用伤口皮肤替代，带来收益成长。由于慢性伤口发生率急剧上升、技术进步导致创新产品开发以及医疗保健成本上升，预计亚太、欧洲和拉丁美洲地区也将强劲成长。

参与企业：

  • Coloplast
  • Smith & Nephew
  • MTF Biologics
  • MiMedx Group, Inc
  • AlloSource
  • Organogenesis Inc.
  • RTI Surgical
  • LifeNet Health
  • Molecular Biologicals, Inc

本报告调查了全球伤口皮肤替代市场，并总结了市场概况、市场规模趋势和预测、按地区/主要国家进行的详细分析、竞争格局和主要企业简介。

目录

执行摘要

第一章 市场

第二章 区域

  • 区域概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 土耳其
    • 荷兰
    • 俄罗斯
    • 瑞士
    • 波兰
    • 奥地利
    • 捷克共和国
    • 瑞典
    • 罗马尼亚
    • 爱尔兰
    • 比利时
    • 希腊
    • 葡萄牙
    • 挪威
    • 斯洛伐克
    • 丹麦
    • 乌克兰
    • 芬兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
    • 马来西亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
  • 其他地区

第三章市场：竞争基准化分析

  • 主要策略/发展
  • 主要企业生态系统

第四章调查方法

Product Code: BHM2078SA

Introduction of Wound Skin Substitutes

The global wound skin substitutes market, valued at $1,181.0 million in 2022, is on a robust growth trajectory and is anticipated to reach $2,062.6 million by 2030. This market is expected to expand at a compound annual growth rate (CAGR) of 7.35% between 2023 and 2030. Driven by the increasing prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, the market is witnessing a surge in demand for innovative and effective wound healing solutions.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2030
2023 Evaluation$1,255.5 Million
2030 Forecast$2,062.6 Million
CAGR7.35%

Technological advancements in biomaterials and the development of more efficient skin substitute products are further fueling this growth. Moreover, the rising geriatric population, which is more prone to chronic conditions, and the expanding capabilities of healthcare infrastructures globally are significant contributors to the market's expansion. This growth has also been supported by a growing focus on improving patient outcomes and reducing the overall healthcare costs associated with chronic wounds.

Regional Segmentation:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Russian Federation
    • Turkey
    • Poland
    • Belgium
    • Sweden
    • Ireland
    • Norway
    • Austria
    • Denmark
    • Finland
    • Portugal
    • Czech Republic
    • Romania
    • Greece
    • Slovakia
    • Ukraine
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Malaysia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • Argentina
    • Chile
  • Rest-of-the-World

The global wound skin substitutes market has been dominated by North America, which held a 78.12% share in 2022. This significant share can be attributed to several factors, including an aging population, the steep rise in the prevalence of obesity that is heavily correlated to diabetes, and the late effects of radiation therapies. These factors have further boosted the adoption of wound skin substitutes among patients, thereby boosting revenue growth. Asia-Pacific, Europe, and Latin America regions are expected to witness significant growth in the wound skin substitutes market due to a surge in the incidence rate of chronic wounds, technological advancements leading to the development of innovative products, and increasing healthcare expenditure.

Recent Developments in the Wound Skin Substitutes Market

  • In July 2023, Coloplast announced an agreement to acquire Kerecis for up to $1.3 billion. Kerecis has pioneered patented technology for treating wounds and burns by utilizing unaltered fish skin.
  • In April 2023, Coloplast (Kerecis) announced MariGen Shield, which integrates the company's proven fish-skin graft with a silicone contact layer for treating chronic and complex wounds.
  • In January 2023, Coloplast (Kerecis) announced the release of two new products for the burn market, GraftGuide Mano and GraftGuide Micro. This latest innovation is a specialized fish skin product tailored for treating burns specifically on the hand.
  • In January 2022, Researchers from the University of Birmingham and the University of Huddersfield, UK, developed a new 3D bioprinting technique that could be used to treat chronic wounds.
  • In October 2021, Coloplast (Kerecis) received authorization from the FDA to market Kerecis Omega3 SurgiBind. This implant is a fish-skin graft that can be implanted for plastic and reconstructive surgical procedures.

How can this report add value to an organization?

Product/Innovation Strategy: By understanding specific regional needs and preferences highlighted in the report, a company can tailor its product development to address local market demands effectively. This might include innovation in skin substitute materials that cater to prevalent wound types in a particular region.

Growth/Marketing Strategy: With detailed regional data, companies can craft precise marketing strategies that resonate with local healthcare providers and patients. This includes choosing the right channels and messages that appeal to the specific demographic and economic conditions of the region.

Competitive Strategy: The report provides an analysis of key competitors in the region, allowing companies to benchmark their products and strategies. Knowing the competitive landscape helps in positioning their offerings more effectively to capture market share.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2019-FY2021. The market size has been estimated for FY2022 and projected for the period FY2023-FY2030.
  • The scope of this report has been carefully derived based on interactions with experts in different companies worldwide. This report provides a market study of upstream and downstream products of wound skin substitutes.
  • The market contribution of wound skin substitutes anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available wound skin substitute solutions. This report has considered and profiled all the key companies with significant offerings in this field.

Primary Research:

The primary sources involve industry experts in wound skin substitutes, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The competitive landscape of the wound skin substitutes market has been characterized by the presence of several key players, each offering a range of specialized products. Coloplast, for instance, has made significant strides with products such as MariGen Shield, GraftGuide Mano, and GraftGuide Micro, which are tailored to address various aspects of wound care, particularly burns and complex wounds. The companies are not only innovating in product development but also expanding their market reach and setting industry standards in the treatment of complex wounds. This dynamic competitive environment underscores the continuous evolution and technological advancement within the wound care industry.

Some prominent names established in this market are:

  • Coloplast
  • Smith & Nephew
  • MTF Biologics
  • MiMedx Group, Inc
  • AlloSource
  • Organogenesis Inc.
  • RTI Surgical
  • LifeNet Health
  • Molecular Biologicals, Inc

Table of Contents

Executive Summary

1 Market

  • 1.1 Product Definition
  • 1.2 Inclusion and Exclusion Criteria
    • 1.2.1 Inclusion
    • 1.2.2 Exclusion Criteria
  • 1.3 Key Questions Answered
  • 1.4 Analysis and Forecast Note
  • 1.5 Key Findings

2 Regions

  • 2.1 Regional Summary
  • 2.2 North America
    • 2.2.1 U.S.
    • 2.2.2 Canada
  • 2.3 Europe
    • 2.3.1 Germany
    • 2.3.2 U.K.
    • 2.3.3 France
    • 2.3.4 Italy
    • 2.3.5 Spain
    • 2.3.6 Turkey
    • 2.3.7 Netherlands
    • 2.3.8 Russian Federation
    • 2.3.9 Switzerland
    • 2.3.10 Poland
    • 2.3.11 Austria
    • 2.3.12 Czech Republic
    • 2.3.13 Sweden
    • 2.3.14 Romania
    • 2.3.15 Ireland
    • 2.3.16 Belgium
    • 2.3.17 Greece
    • 2.3.18 Portugal
    • 2.3.19 Norway
    • 2.3.20 Slovakia
    • 2.3.21 Denmark
    • 2.3.22 Ukraine
    • 2.3.23 Finland
  • 2.4 Asia-Pacific
    • 2.4.1 China
    • 2.4.2 Japan
    • 2.4.3 India
    • 2.4.4 South Korea
    • 2.4.5 Australia
    • 2.4.6 Thailand
    • 2.4.7 Malaysia
  • 2.5 Latin America
    • 2.5.1 Brazil
    • 2.5.2 Mexico
    • 2.5.3 Argentina
    • 2.5.4 Colombia
    • 2.5.5 Chile
  • 2.6 Rest-of-the-World

3 Markets - Competitive Benchmarking

  • 3.1 Key Strategies and Developments
  • 3.2 Key Companies Ecosystem

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Wound Skin Substitutes Market, $Million, 2022, 2026, and 2030
  • Figure 2: Global Wound Skin Substitutes Market (by Region), $Million, 2022, 2026, and 2030
  • Figure 3: Key Industry Trends in Global Wound Skin Substitutes Market
  • Figure 4: U.S. Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 5: Canada Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 6: Germany Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 7: U.K. Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 8: France Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 9: Italy Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 10: Spain Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 11: Turkey Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 12: Netherlands Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 13: Russian Federation Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 14: Switzerland Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 15: Poland Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 16: Austria Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 17: Czech Republic Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 18: Sweden Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 19: Romania Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 20: Ireland Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 21: Belgium Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 22: Greece Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 23: Portugal Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 24: Norway Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 25: Slovakia Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 26: Denmark Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 27: Ukraine Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 28: Finland Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 29: China Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 30: Japan Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 31: India Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 32: South Korea Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 33: Australia Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 34: Thailand Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 35: Malaysia Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 36: Brazil Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 37: Mexico Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 38: Argentina Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 39: Colombia Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 40: Chile Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 41: Data Triangulation
  • Figure 42: Top-Down and Bottom-Up Approach
  • Figure 43: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Wound Skin Substitutes Market, Opportunities
  • Table 3: Global Wound Skin Substitutes Market (by Region), $Million, 2021-2030
  • Table 4: North America Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 5: Europe Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 6: Asia-Pacific Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 7: Latin America Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 8: Rest-of-the-World Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 9: Key Initiatives, 2021-2024
  • Table 10: Key Companies, Global Wound Skin Substitutes Market